1. Home
  2. MRKR vs GTEC Comparison

MRKR vs GTEC Comparison

Compare MRKR & GTEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRKR
  • GTEC
  • Stock Information
  • Founded
  • MRKR N/A
  • GTEC 2006
  • Country
  • MRKR United States
  • GTEC United States
  • Employees
  • MRKR N/A
  • GTEC N/A
  • Industry
  • MRKR Biotechnology: Pharmaceutical Preparations
  • GTEC Industrial Machinery/Components
  • Sector
  • MRKR Health Care
  • GTEC Industrials
  • Exchange
  • MRKR Nasdaq
  • GTEC Nasdaq
  • Market Cap
  • MRKR 19.1M
  • GTEC 19.7M
  • IPO Year
  • MRKR N/A
  • GTEC N/A
  • Fundamental
  • Price
  • MRKR $1.47
  • GTEC $2.03
  • Analyst Decision
  • MRKR Strong Buy
  • GTEC
  • Analyst Count
  • MRKR 3
  • GTEC 0
  • Target Price
  • MRKR $13.17
  • GTEC N/A
  • AVG Volume (30 Days)
  • MRKR 231.4K
  • GTEC 98.7K
  • Earning Date
  • MRKR 08-13-2025
  • GTEC 08-14-2025
  • Dividend Yield
  • MRKR N/A
  • GTEC N/A
  • EPS Growth
  • MRKR N/A
  • GTEC N/A
  • EPS
  • MRKR N/A
  • GTEC 1.14
  • Revenue
  • MRKR $5,696,123.00
  • GTEC $82,898,634.00
  • Revenue This Year
  • MRKR N/A
  • GTEC $3.28
  • Revenue Next Year
  • MRKR $11.28
  • GTEC N/A
  • P/E Ratio
  • MRKR N/A
  • GTEC $1.82
  • Revenue Growth
  • MRKR 71.53
  • GTEC N/A
  • 52 Week Low
  • MRKR $0.95
  • GTEC $1.17
  • 52 Week High
  • MRKR $5.99
  • GTEC $2.94
  • Technical
  • Relative Strength Index (RSI)
  • MRKR 50.81
  • GTEC 51.66
  • Support Level
  • MRKR $1.41
  • GTEC $2.01
  • Resistance Level
  • MRKR $1.53
  • GTEC $2.26
  • Average True Range (ATR)
  • MRKR 0.16
  • GTEC 0.09
  • MACD
  • MRKR -0.03
  • GTEC -0.01
  • Stochastic Oscillator
  • MRKR 9.43
  • GTEC 38.87

About MRKR Marker Therapeutics Inc.

Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from its MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets.

About GTEC Greenland Technologies Holding Corporation

Greenland Technologies Holding Corp is a developer of quality solutions in the material handling industry. It is a transmission and drivetrain systems provider for material handling equipment such as forklift trucks for industrial and logistic applications. Geographically, the company has its presence in Domestic and International markets and earns majority of the revenue from Domestic Sales.

Share on Social Networks: